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Autopsy liver material from patients having died of chronic 
liver disease, cirrhosis, hepatocellular carcinoma (HCC) and 
causes unrelated to liver diseases was examined by dot blot 
hybridisation for the presence of HBV DNA. The results 
indicate that of the patients with chronic liver disease 6/9 
were positive for HBV DNA in the liver tissue; of the patients 
with HCC 3/4 were positive for HBV DNA; of the patients with 
cirrhosis . 4/4 showed the presence of HBV DNA in the liver. 
Thus by this technique 13/17 (76%) of these patients, all of 
whom were HBsAg positive, were shown to have HBV DNA present in 
liver tissue. However, autopsy liver samples were found to be 
unsuitable for Southern blot hybridisation . 
Biopsy liver/tumour tissue was examined for the presence of 
integrated or non-integrated HBV DNA by Southern blot analysis 
using the enzymes Eco R1 and Hind 111. 5/5 patients who were 
both HBsAg and HBeAg positive had extrachromosomal HBV DNA and 
2/5 also showed the presence of integrated HBV DNA. 3/4 
patients who were HBsAg positive and HBeAg negative had 
extrachromosomal HBV DNA and all three also had integrated HBV 
DNA. One control patient was negative for both markers and 
also for Southern blot hybridisation with the HBV DNA probe. 
These results support the hypothesis that HBV is a factor in 
the aevelopment of HCC, and indicate t hat the dot blot 
hybridisation method would be suitable for routine evaluation 
6f patients with chronic liver disease or cirrhosis. 
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CHAPTER 1 GENERAL INTRODUCTION 
1.1 HISTORY, CLINICAL EXPRESSION AND EPIDEMIOLOGY 
In 1960 Blumberg carried out a study on the polymorphism 
of human antigens i n blood samples collected worldwide 
from patients who had received a large number of blood 
transfusions. The studies entailed a search for 
antibodies against unique antigens which differed from the 
normal blood group antigens (Blumberg, 1965). A simple 
Ouchterlony immunodiffusion test revealed a line of 
precipitation between an antibody present in the blood 
of an haemophiliac from New York, who had received a 
number of transfusions, 
Australian aborigine. 
Australia antigen or Au. 
and an antigen present in an 
Thus the antigen was termed 
Subsequently, a correlation was 
shown to exist between the Au antigen and hepatitis, an 
infection of the liver in humans. This relationship was 
confirmed in 1967, when a technologist in Blumberg's 
.laboratory developed hepatitis whilst purifying the Au 
antigen. 
blood 
Thereafter it was revealed that transfusion of 
containing the Au antigen resulted in the 
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development of hepatitis in the recipient. The Au 
antigen, also referred to as hepatitis associated antigen 
(HAA), is now known as hepatitis B surface antigen 
(HBsAg). The presence of the antigen and its corresponding 
antibody can be detected by laboratory testing of blood. 
This 
well 
is of extreme importance in blood transfusion, 
as other services such as haemodialysis, 
as 
and 
exclusion of HBsAg positive individuals has significantly 
reduced the rate of transmission of the virus now known as 
hepatitis B virus (Blumberg, 1977). 
Serum hepatitis (hepatitis type B), whose causal agent is 
hepatitis B virus (HBV), is sporadic in occurrence and has 
a variable incubation period of 2 to 26 weeks. 
Transmission is predominantly by the parenteral route, but 
there is now increasing evidence for the spread of HBV by 
non-parenteral routes such as experimental transmission of 
HBsAg-positive semen and saliva in non-human primates 
(Evans, 1982). 
Clinical expression following HBV infection is variable 
and usually asymptomatic, recognisable only by the 
detection of HBV markers in the serum. Only about 10% of 
~infected adults develop a clinically recognisable 
hepatitis and this percentage is lower in infants and 
children (Beasley and Hwang, 1984~ 
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Fig. 1. The serological, clinical and biochemical events associated 
with the typical course of acute B virus hepatitis (Kew, 
1983) • 
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HBV infection is associated with the appearance of HBsAg 
in the serum from 2 to 8 weeks before biochemical evidence 
of liver damage or the onset of jaundice (Fig. 1). This 
antigen persists during the acute phase of infection but 
is usually cleared from the circulation during 
convalescence. The appearance of HBsAg is followed by the 
detection of high levels of the enzyme DNA polymerase 
which is associated with the core or nucleocapsid of the 
virus, and also of the le l antigen (HBeAg). Antibody 
) 
secreted against the core (anti-HBc) is found in the serum 
2 to 4 weeks after the appearance of HBsAg and antibody to 
HBeAg (anti-HBe) appears slightly later, its detection 
coinciding with the loss of detectable amounts of HBeAg. 
However, antibody to HBsAg (anti-HBs) is often only 
detectable 4 to 5 months following the detection of HBsAg 
in the serum (Zuckerman, 1979). 
In clinically apparent HBV infections, symptoms range from 
fatigue and loss of appetite to severe malaise, coma and 
even death. It has been said that "jaundice is the 
hallmark of hepatitis", however, only a minority of 
infected persons ever experience it. Hepatitis B infection 
is atso frequently accompanied by fever, chills and 
gastrointestinal symptoms, such as nausea and abdominal 
discomfort (Beasley and Hwang, 1984). 
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Some individuals do not eliminate the virus after 
infection with HBV but become chronic carriers. The 
factors determining the severity of the clinical response 
as well as the reason for progression to the carrier state 
and chronic liver disease are poorly understood, but 
chronic infection, once established, may last for many 
years (Beasley, 1983). It is believed that the 
immunologic status, age and sex of the infected 
individual may influence the likelihood of progression to 
the carrier state. Certainly HBs antigenaemia is known to 
be less prolonged in females for reasons that are not 
understood (Beasley and Hwang, 1984). 
The age at which HBV infection occurs is one of the 
factors determining progression to the carrier state, the 
probability of becoming a carrier being inversely related 
to the age at which onset of infection takes place. 
According to Okada et ~., (1976) and 8easley and Hwang, 
(1984), at least 85% of infected newborns become carriers, 
whereas less than 10% of infected adults become carriers. 
The ~usceptibility of infants to the carrier state may be 
related to a relative immaturity of their immune system 
• 
(~wang et ~., 1983; Lee et ~., 1983). 
There are three types of chronic hepatitis: chronic 
persistent hepatitis, chronic active hepatitis and chronic 
7 
lobular .. hepatitis. Chronic persistent is usually 
asymptomatic and has a good prognosis because there is 
minimal liver damage. Chronic active and chronic lobular 
hepatitis, however, are severe and have a poor prognosis 
because of the extensive liver damage associated with 
these types of hepatitis. Thus it is not surprising that 
chronic active hepatitis might lead to macronodular 
cirrhosis and could eventually progress to hepatocellular 
carcinoma (HCC). 
HBV may be involved in the aetiology of human HCC because 
of the observation that HBV infection often precedes the 
development of the tumour, the similarity between the 
geographical distribution of chronic carriers of HBsAg and 
the incidence of HCC, and the increase in the prevalence 
of HBV markers in the serum of patients with HCC compared 
to that seen in the general population (Kew, 1978). 
Beasley and Hwang, (1984), also reported that world wide, 
areas with high HBsAg prevalence have a high incidence of 
HCC, whereas areas with low HBsAg prevalence have a low 
incidence of HCC. For instance, both HBsAg carrier states 
and HCC incidence appear to be universally high among 
Black South Africans but are very low among American 
Blacks. In contrast the incidence of HCC among South 
8 
African Whites is low, being similar to that seen in 
Caucasians in Western Europe and the United States. Their 
prospective study in Taiwan also showed that HBV 
carriers there have approximately a 200-fold higher risk 
of developing HCC than have noncarriers, and the lifetime 
risk of a chronic carrier developing HCC may be as high as 
50% in males. They also consider that other environmental 
factors such as aflatoxins may be involved in the 
development of HCC in persons who are HBV carriers. 
There is also evidence to suggest that increasing severity 
of cirrhosis is associated with increased risk of HCC 
(Koshy et~., 1981). HCC is a serious disease, with a 
poor prognosis. The tumour frequently affects young 
people. Because epidemiologic studies have established a 
close association between the occurrence of HCC and 
chronic HBV infection, the development of an inexpensive 
HBV vaccine is likely to be the key factor in leading to 
"ultimate eradication" of HBV infection and hence 
presumably of much HCC. 
1. 2 THE VIRUS 
... 
The use of recently developed methods for gene cloning and 
molecular hybridisation techniques has allowed detailed 
9 
investigation of the biology of HBV and mechanisms 
involved in HBV-host cell genome interactions. 
HBV is a DNA containing virus with certain unique 
features; its characterisation has led to the 
esatablishment of a new group of viruses, the 
Hepadnaviruses. The virus is a double-shelled, roughly 
spheroidal particle, either empty or full consisting of a 
small core and a lipoprotein polypeptide outer envelope 
(Dane, 1970). Krupp and Chatton, (1982), described 
spherical and tubular particles of different sizes which 
were present in the serum of patients with hepatitis B, 
and which possessed a common antigenicity. 
Fi g. 2. 
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Spherical partic le Tubular particle 
Diagrammatic representation of HBV particles and their 
associated antigens (Kew, 1983). 
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The largest of these spherical forms was first described 
by Dane, (1970), and is considered to be the complete 
hepatitis B virion (Fig. 2). The Dane particle is 42nm in 
diameter and consists of a 27nm core surrounded by an 
outer coat or envelope composed of HBsAg. Within infected 
cefls the core is found in the nucleus and the double 
shelled outer coat material is found in the cytoplasm 
(Krupp and Chatton, 1982). The core, or nucleocapsid, 
contain double and single stranded DNA and the two enzymes 
DNA polymerase and a protein kinase. It is thought that 
the DNA -polymerase reaction completes the single stranded 
DNA to produce a double stranded form, while the protein 
kinase may assist i n the DNA replication. The viral DNA 
codes for the outer coat material (ie HBsAg) in excessive 
amounts and material not utilised in coating nucleocapsids 
leaves the cells as small spherical or tubular particles 
which circulate in the plasma. A further HBV-associated 
antigen which is found in the plasma is the le l antigen . 
This is a soluble antigen, circulating alone or complexed 
with immunoglobulin, whose relationship to the virion was 
originally obscure but which is now recognised as a Signal 
peptide affecting t he excretion of virus (Krupp and 
'thatton, 1982). 
12 
HBV has a small circular DNA genome of 3200 to 3300 base 
pairs. This genome has a unique structure having an L or 
long strand which is complete except for a nick of one or 
a few nucleotides at a fixed point (1800 nucleotides from 
the Eco R1 site) and an S or short strand which is 
incomplete , missing from 15 to 50% of its potential 
sequence complement. The 5'end of the S strand is located 
at the nucleotide 1560 position but the pOSition of the 3' 
end varies considerably. The circular configuration of the 
molecule is maintained by the base pairing of the 5' 
extremities of both strands which overlap by 250 to 300 
nucleotides to form a cohesive end region (Fig. 3) 
(Sherman and Shafritz, 1984). 
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Fig. 3. Restriction map of the genome of HBV showing 
restriction enzyme sites and the open reading 
frames and genes on the L strand (Sherman and 
Shafritz, 1984). 
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1.3 DIAGNOSTIC METHODS 
Insensitive methods, such as the Ouchterlony double 
diffusion test, were first used to detect HBsAg. However, 
for present diagnosis of HBV infection highly sensitive 
radioimmunoassays (RIA) or enzyme immunosorbent assays 
(ELISA), involving the use of radiolabelled or enzyme -
labelled reagents are used to detect a wide range of HBV 
markers. These markers include HBsAg, Anti-HBs, anti-HBc, 
HBeAg and anti-HBe. As excessive amounts of HBsAg are 
produced early in infection during viral replication and 
the s genes may in some cases be the only regions 
expressed during persistent infection, detection of HBsAg 
has provided the most reliable method for diagnosis of 
acute infection and of the HBV carrier state. Anti-HBs, on 
the other hand, is a late marker of HBV infection and its 
presence in high levels in the serum may indicate past 
infection and immunity. HBcAg may be detected in the 
nuclei of infected liver cells using a fluorescent 
antib~dy technique (Hoofnagle et ~., as cited by 
Zuckerman, 1979). Anti-HBc is present in the serum of 
• 
chronic carriers, and also in individuals recovering from 
HBV infection. The detection of HBeAg in patient serum may 
be taken as a reliable indicator of the presence of 
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infectious Dane particles in the blood, and there is a 
significant correlation between HBeAg, infectivity, DNA 
polymerase activity and the presence of complete virus 
particles circulating in the blood. Conversely, the 
presence of anti-HBe in the serum usually signifies 
reduced or relatively low activity. Virus production, 
however, has been reported in the presence of anti-HBe in 
some carriers. 
Serum cont aining very low levels of replicating viral 
particles may be HBeAg negative but HBV DNA can be 
detected in serum by molecular hybridisation. The method 
for HBV DNA detection by molecular hybridisation may 
therefore be more sensitive for the detection of complete 
virus particles than the conventional radioimmunoassays 
for HBeAg. 
1.4 STUDIES ON INTEGRATION OF THE VIRAL GENOME 
1.4.1 Cloning of the HBV genome 
Since HBV cannot be grown in tissue culture and 
normally infects only man and apes, molecular 
16 
studies of the virus and its genome were based on 
the limited amounts of material obtainable from the 
plasma of infected individuals. 
Burrell and coworkers (1979) inserted fragments of 
HBV DNA isolated from Dane particles into the 
plasmid pBR322 and cloned it in ~ coli. Some of the 
transformed cells carrying the hybrid plasmid 
synthesize antigenic material that reacts 
specifically with antisera to hepatitis B viral 
antigens. Cloning of DNA from HBV of three different 
serotypes in E. coli. via phage derivatives and 
plasmids has also been reported (Pasek et al., 
1979). Valenzuela et ~., (1979), examined a full 
length clone by restriction endonuclease activity 
analysis, and the nucleotide sequence of an 892 
base pair fragment from cloned hepatitis B viral 
DNA, encoding the surface antigen gene, was 
determined. The amino acid sequence deduced from 
this nucleotide code showed the surface antigen to 
be a protein consisting of 226 amino acids and with 
~ a molecular weight of 25 398 daltons. Valenzuela and 
co-workers also found that the portion of the gene 
coding for this protein apparently contains no 
intervening sequences. 
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The HBV genome has now been studied in great detail 
and it is now possible to obtain cloned HBV DNA of 
known nucleic acid sequence which can be used as a 
probe in diagnostic studies. 
1.4.2 HBV DNA integration studies 
As described above (1.1) hepatitis is a common and 
sometimes severe disease with 10-20% of the 
population in some parts of Africa and Asia being 
chronic carriers of viral surface antigen. 
In 1980, Alexander and co-workers developed a tissue 
culture cell line (PLC/PRF/5) from the HCC of a 
Mozambican male with HBs antigenaemia. This cell 
line produces and secretes HBsAg but no other viral 
prote ins (Chakraborty et ~., 1980; Brechot et ~., 
1980) . PLC/PRF/5 therefore contains at least part 
of the HBV genome in functional form. It was pOinted 
out that the presence of integrated HBV DNA in this 
<t. HCC cell line as well as in HCC liver material 
favours the argument for HBV as a cofactor in HCC 
(Chakraborty et ~., 1980; Brechot et al., 1980 and --
Edman et ~., 1980). Subsequently, Shafritz et ~., 
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(1981), studied HBV DNA in the liver of chronic HBV 
carriers in the United States. They showed that 
short term carriers, namely patients who have been 
positive for HBsAg for longer than six months but 
less than two years, do not generally have 
detectable integrated HBV DNA by Southern blot 
analysis, irrespective of the presence of liver 
disease. These patients are usually HBeAg positive, 
DNA polymerase positive and have circulating Dane 
particles in the peripheral blood. Large amounts of 
free viral DNA are present in the liver at this 
stage. In contrast, anti-HBe positive patients may 
have detectable HBV DNA integration (Brechot et ~., 
1981). Based on these studies two forms of chronic 
hepatitis B can be recognised: 
a) "Replicative" hepatitis B, in which carriers are 
HBsAg, HBeAg, HBV DNA positive. These individuals 
have episomal HBV DNA within hepatocytes. This state 
represents a relatively early form of the disease. 
b) In patients with long-standing hepatitis B, 
only low levels of HBV replication, or absence 
of replication predominates. These persons are 
HBsAg positive, and anti-HBe positive, but 
19 
HBeAg and HBV DNA negative, with HBV DNA 
integrated within the host genome. Presumably 
their HBsAg is coded from an integrated HBV 
template. 
By analogy with animal tumour viruses, such as 
adenoviruses and SV40, if HBV has a causal role in 
HCC, it might be expected to be integrated into the 
host DNA in tumour cells in chronic HBV carriers. 
... 
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EXTRA CHROMOSOMAL HBV DNA 
(a) Linear (Eco RI) 
3.3 kb 
+ 
Fig. 4(i). Extrachromosomal HBV DNA as present in the 
hepatocytes or serum 
INTEGRATED HBV DNA 
(b) undigested (c) Hind III (d) Eco RI 
+ 
3.2 kb 
- 3.3 kb 
Fig.4(ii). Hypothetical results disting~ishing undigested 
Fi g. 4. 
" , 
and digested integrated HBV · DNA 
Strategy for restriction enzyme analysis of 
hepatitis B virus DNA (Adapted from Sherman 
and Shafritz, 1984). 
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Different restriction enzymes can be used to 
distinguish between integrated and non-integrated 
HBV DNA. 
The enzyme Eco R1 cuts once within the HBV genome. 
Thus, free circular HBV DNA will be cleaved by Eco 
R1 to yield a linear molecule which migrates like 
the circular form on gel electrophoresis to form a 
band at the 3200 to 3300 base pair position (Fig. 
4(i)a). However, integrated HBV DNA if untreated, 
forms a diffuse band at the top of the gel, while 
an Eco R1 digest will produce high molecular weight 
molecules consisting of part of the HBV DNA linked 
to host cell DNA (Fig. 4(ii)). If concatemers (fully 
replicated HBV genomes remaining linked together) or 
oligomers (li near tandem repeats of the HBV DNA) are 
present, 3200 to 3300 base pair length molecules 
will also be produced. 
The enzyme Hind 111 , which does not cut the HBV 
genome, may be used to distinguish between specific 
and random integration of HBV DNA. The former is 
, 
def i ned by the specific banding of molecules larger 
" , than the viral genome ( le > 3200 to 3300 base 
~pairs), while the latter will produce only a diffuse 
smear on gel hybridisation analysis following Hind 
111 digestion (Sherman and Shafritz, 1984). 
22 
Research has shown that HBV DNA is integrated into 
the cellular DNA of HCC HBsAg carriers at a very 
high rate (Hino et ~., 1984), and the integration 
pattern differs from case to case. However, as some 
similarities in pattern are seen it is possible that 
there are some preferred sites of viral integration 
(Koshy et ~., 1981). 
The molecular basis for the pathogenesis of HCC 
associated with hepatitis B virus is unknown. 
Several aspects of hepadnavirus replication resemble 
the mechanism of retrovirus replication. Like 
retroviruses, all known HBV coding genes are located 
on one strand of the virus and are in the same 
orientation. However, unlike retroviruses, 
integration does not appear to be necessary for 
hepadnavirus replication. The cohesive end regions 
of hepadnaviruses are structurally similar to 
retroviral long terminal repeats and may serve an 
analogous function. Murray et ~ ., (1981) showed 
that retroviral oncogenes transferred into recipient 
cells induce neoplastic transformation of those 
cells. Howeve r , transfection of HBV DNA has failed 
thus far to produce neoplastic transformation and so 
it may not tontain an oncogene as such. Moreover, 
,HBV DNA does not contain sequence homology to any of 
the known retroviral oncogenes. However, Chakraborty 
et ~., (1981), have identified two strong viral 
promoters in HBV, one in the cohesive end region and 
the other in the pre-S region, and it has been 
.. 
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noted that in hepadnavirus integrations the cohesive 
end regiDn with its strong promoter has been 
conserved. 
Two possibilities outlined by Dejean et al., (1983), --
may explain the oncogenicity of HBV. The first 
possibility is that the promoter-containing region 
becomes integrated adjacent to a cellular proto-
oncogene or another transforming gene. However, in 
those human tumours studied to date, no sequences 
homologous to any of the known retroviral oncogenes 
have been found directly adjacent to an integrated 
HBV gene. An alternative possibility is that during 
persistent infection, cellular oncogenic sequences 
could become integrated into the HBV genome creating 
a mutant, autonomously replicating tumour virus. 
This mutant virus could then infect other 
hepatocytes, resulting in enrichment of oncogenic 
sequences in recipient cells and in their 
subsequent transformation. 
Wen et ~., (1983) showed that neoplastic 
transformation by a DNA tumour virus depends on the 
presence of certain virus coded antigens, the 
transformation or T antigens. A protein similar to 
a T antigen has not been described for HBV, but a 
nuclear antigen similar to that found in Epstein 
Barr virus transformed cells has been described. 
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Sherman and Shafritz, (1984) have pOinted out that 
integration of SV40 and other DNA tumour viruses 
appears to be a random or semi-random event, 
occurring at no fixed site in the cellular or viral 
genome. Rather like SV40, HBV DNA is integrated into 
host DNA in a complex fashion, with inversions and 
deletions of viral DNA and with rearrangements of 
cellular sequences at the site of integration. 
However, no specific gene expression product 
associated with or responsible for transformation 
has so far been identified. 
Recently Boender and co-workers (1985) suggested 
that a number of factors may be responsible for not 
detecting site specific HBV DNA integration into the 
human genome by either Southern blot or other 
methods of analysis. The failure to detect specific 
integration could be caused by a number of factors 
such as the presence of a substantial number of 
copies of HBV in the tumours, the relatively short 
regions of integrations, rearrangements or deletions 
occurring during or after the construction of the 
cell lines, or integration within a highly 
polymorphic region of the host cell genome. 
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Thus, molecular studies have resulted in a detailed 
knowledge of the HBV genome with respect to its 
integration into the host cell DNA and its 
relationship to cirrhosis, and also HBV DNA, 
because of its integration into the human genome and 
its association with HCC, has often been considered 
to be oncogenic. 
1.5 THE PRESENT STUDY 
Windsor and Joseph (1981), reported that of the total 
number of cases of hepatitis studied in African Black 
patients in Natal, 11% were due to an HAV infection and 
41% to an HBV infection. Also, in 1983, Windsor and Simjee 
showed that of the 43 Black African HCC -patients studied 
over a period of 14 months, 60% were HBsAg positive and 
80% had markers of HBV infection, while of the 65 
cirrhotic patients studied, 33% were HBsAg positive and 
75% ~ad HBV markers. From Table 1, which depicts the 
numbers of · patients tested for and those found positive 
~ 
for HBsAg at King Edward V111 Hospital, Durban, over a 6 
month period in 1986, it can be concluded that HBV 
infection in Natal is extensive. 
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TABLE 1. Hospital patients tested for HBV infecton in Natal 
of, 
over a period of 6 months 
Month No of pts no HBsAg+ % 
Jan 690 152 (22) 
Feb 819 104 ( 12) 
Mar 1708 188 ( 11) 
Apr 1174 162 (13.7) 
May 814 87 (10.0) 
Jun 837 126 ( 15.0) 
Mean 6049 819 ( 13.9) 
The majority of the studies on HBV and HCC in Natal have 
therefore been carried out on Black African patients 
because of the high prevalence of HBV infection in this 
population group. 
In the present study, both Southern and dot blot 
hybridisation methods were applied to the detection of HBV 
DNA in total DNA extracted from liver and tumour specimens 
obtained ·from patients with acute and chronic hepatitis B, 
in the hope of expanding our knowledge of the role of HBV 
in this group. 
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CHAPTER 2 INTRODUCTION TO THE METHODOLOGY 
THEORETICAL CONSIDERATIONS 
2. 1 GEL ELECTROPHORESIS 
.. 
Agarose is the most common medium for nucleic acid gel 
electrophoresis. The three different types available 
include GTG agarose for high molecular weight DNA and NU 
Sieve agarose for small DNA fragments. Different 
concentrations of agarose, ie. from 0.6 to 1.8% can be 
used to electrophorese DNA or RNA. The voltage can be 
varied depending upon the size of the DNA, the 
concentration of agarose used and individual preference. 
The choice of the different parameters also depends upon 
the type of research being undertaken. 
At neutral or alkaline pH, the phosphate groups of DNA 
give rise to a uniform negative charge per unit length of 
the DNA molecule. Thus in an electric field, DNA will move 
towards the anode, with a constant driving force per unit 
length propelling the molecules, regardless of base 
. 
composition. Any differences in the rate of movement of 
different DNA molecules will depend only on their 
resistances to their movements. If the molecules are in 
the gel they will have to pass through its pores as they 
move towards the anode. The longest molecules will have 
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most difficulty in passing through the pores, and may even 
be blocked completely, whereas the smallest molecules will 
be relatively unhindered. Consequently the velocity of 
movement of a DNA molecule during ge l electrophoresis will 
depend on its size, the smallest mo lecules moving fastest 
because the separation depends on chain length rather 
than molecular weight of the molecules. Thus DNA lengths 
are referred to as "X number of base pairs" (bp) if double 
stranded or "X number of nucleotides" (nt) if single 
stranded. The influence of shape and size rather than 
molecular weight, is demonstrated by the fact that gel 
electrophoresis can be used to separate different physical 
forms of the same DNA from each other, eg covalently 
closed circular, open circular and linear forms of a 
plasmid DNA will have different mobilities (Boffey, 1983). 
2.2 RESTRICTION ENZYME NUCLEASES 
A restriction endonuclease is an enzyme that recognises a 
~pecific base sequence in a DNA molecule and makes two 
cuts at that position, one in each strand, thus 
generating 3'-OH and 5'-P tremini. Roughly 400 different 
restriction enzymes have 
different microorganisms 
been purified from 
and approximately 
about 250 
150 a re 
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commercially available. All but a few of these enzymes 
recognise sequences having rotational (dyad) symmetry, 
that is, the recognition site generally has a sequence 
whose form is: 
, 
A 8 C or A 8 XI 8' A' 
------' 
C 8 A A' 8 ' X 8 A 
in which the capital letters represent bases, a prime 
indicates a complementary base, X is any base, and the 
dashed line is the axis of symmetry. Sequences having more 
than 6 bases are known but none have been observed 
containing fewer than 4 bases (Freifelder, 1983). 
The two enzymes used in this study were the Eco R1 enzyme 
of E. coli which cleaves at the recognition site AAGCTT, 
and the Hind 111 
TTCGAA 
enzyme of Haemophilus influenzae which 
cleaves at the recognition site GAATTC. 
CTTAAG 
Restriction enzymes vary greatly in their stability and 
their ability to tolerate contaminants. The enzymes also 
show variation of activity depending upon pH, buffer and 
salt composition. Furthermore, DNA may contain ionic 
compopnds which can reduce the efficiency of the 
.. 
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restriction endonuclease cleavage. Thus these enzymes are 
sensitive to optimal conditions required for activity. 
2.3 SOUTHERN BLOTTING 
Gel electrophoresis is a powerful tool for the separation 
and resolution of complex mixtures of proteins and or 
nucleic acids. However, the correlation of a band or spot 
on a gel with particular functional and structural 
entities is often difficult and gels require careful 
handling. Further manipulations are usually time consuming 
and inefficient because the separated samples are located 
within the gel matrix. 
A technique for the transfer of separated macromolecules 
onto the surface of a membrane was first developed for DNA 
by Edwin Southern of Edinburgh University (1975) and has 
since been extended to RNA "Northern blot" and protein 
"Western blot". These blotting procedures offer a 
solution to the problems posed in the identification of a 
molecule after gel electrophoresis, since once 
.. 
transferred, the molecule may be effectively immobilised 
on the membrane surface. Membranes are relatively easy to 
handle and thus allow much more efficient analysis of 
these macromolecules. 
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The ability to immobilise mlecules at the surface of a 
membrane has been exploited in a variety of applications 
other than those involving gel electrophoresis, such as 
dot blotting and colony/plaque screening. Most of these 
techniques were originally developed using nitrocellulose 
(NTC) filter papers or their derivatives. However, nylo"n 
based membranes have recently been reported to have 
advantages in a variety of applications, due to their high 
physical strength and the avidity with which 
macromolecules are bound. Thus Hybond-N membrane was used 
for both Southern and dot blotting (Amersham Research 
Laboratories (ARL), 1985). 
The DNA is carried out of the gel by the flow of solvent 
and trapped in the Hybond-N paper. It has been found that 
several factors affect the eficiency of the transfer 
procedure. For instance, DNA fragments larger than 10Kb in 
size are transferred very slowly, and should be broken 
down in the gel before transfer. This can be done either 
by irradiating the gel with shock wave UV rays before 
denaturation, or by partial depurination with dilute 
acid followed by strand cleavage with an alkali. However, 
the effectiveness of the irradiatioin method has been 
disputed. Secondly some brands of NTC filter paper seem to 
retain DNA more effectivley than others. Finally, the 
~time of transfer will depend upon the thickness of the 
gel, the percentage of agarose in the gel and the sizes 
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of the fragments to be transferred (Matthew, 1983). 
2.4 DOT BLOTTING 
A dot blot hybridisation method has been used (Kafatos et 
al., 1979), for rapidly determining the relative 
concentrations of nucleic acids in a mixture, as well as 
the extent of sequence homology between related RNA or 
DNA species. Multiple samples of DNAs, identical in 
quantity, are spotted next to each other on a single NTC 
filter, in dots of uniform diameter. The filter is then 
hybridised with a radioactive probe, such as an RNA or DNA 
mixture which may contain the corresponding sequences in 
unknown proportions. Conditions are chosen to avoid 
saturation of the filter bound DNA. The extent of 
hybridisation with each of the DNA dots is evaluated 
semi-quantitatively after autoradiography, by visual 
comparison to a standard consisting of a dilution series 
of radioactive DNA, similarly spotted on an NTC filter in 
dots of the same diameter. This approach may be used for 
the evaluation of the relative abundance of nucleic acid 
sequences in a mixture. Moreover dot hybridisation under 
progressively more stringent conditions can be used for 
semi-quantitative evaluation of the extent of similarity ~. 
between homologous sequences (Kafatos et il., 1979). 
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2.5 PLASMID ISOLATION 
Some bacterial genes are not located in the main 
chromosomal DNA but in independently replicating molecules 
of circular, double-stranded DNA cal led plasmids. Plasmids 
vary in size depending upon the organism in which they are 
found, eg pBR322 has 4362 whereas M13 has 7229 bp. Many 
plasmids carry gene markers which code for antibiotic 
resistance, antibiotic synthesis, toxin production, 
nitrogen fixation, production of degradative enzymes and 
conjugation. So plasmids are obviously of great interest 
in their own right. However, in the context of this 
research, plasmids are mainly of interest as vectors for 
the cloning of DNA. It is possible to obtain large 
quantities of a particular DNA by inserting it into 
plasmid (vector) DNA which can then be introduced into a 
suitable host bac t erium in which the plasmid will 
replicate. Culture of the bacteria will result in the 
production of more plasmid DNA, which can then be isolated 
{rom the cells and the inserted DNA recovered. 
As Boffey (1983), pointed out, most of the plasmids used 
as cloning vectors do not occur in nature, but have been 
extensively modified so that they have properties useful 
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for cloning, eg pBR322 contains ampicillin and 
tetracycline resistance genes alllowing identification of 
transformants (ampr, tet r ) or recombinants (amps tet r or 
ampr tets ). These markers are extremely useful, being 
widely employed for selection and maintenance of the 
plasmid in bacterial cultures. The plasmid must be 
replicated in the host cell and if the replication is 
relaxed (ie not stringently coupled to chromosomal DNA 
replication) there is the possibility of increasing the 
number of plasmid copies up to seven thousand per cell by 
selectively inhibiting protein synthesis and hence 
chromosomal DNA replication. This results in higher yields 
of plasmid DNA with respect to chromosomal DNA. The 
isolation of pure, intact plasmid DNA in high yields is 
made simpler if the plasmid is small. Small plasmids are 
relatively resistant to shearing and will therefore remain 
in their native supercoiled, covalently closed circular 
(CCC) form, whilst the high molecular weight chromosomal 
DNA will be broken into large linear fragments. These 
differences in size and shape can be exploited to 
• separate the two types of DNA from each other. Desirable 
characteristics of the host bacterium include ease of 
transformation, of culture and of lYSis (Boffey, 1983). 
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2.6 NICK TRANSLATION 
If a single-stranded DNA molecule is placed in contact 
with a complementary single stranded DNA sequence, the two 
molecules will associate with one another by hydrogen 
bonding between the bases on their respective strands. 
This association, or hybridisation, forms the basis of 
very powerful techniques for detecting and quantifying 
specific nucleic acid sequences. Whether the hybridistion 
is done in solution or using nucleic acid immobilised on 
filters, a radioactively labelled probe is required. The 
enzyme, DNA polymerase 1 from ~ coli catalyses a reaction 
which can be used to replace existing unlabelled 
nucleotides in DNA with radioactive ones. The reaction has 
been called nick translation and is very widely used in 
molecular biology (Matthew, 1983). 
The initial step in the procedure is to create free 3'_ 
hydroxyl .. (OH) groups within the unlabelled DNA by means 
of a nuclease such as pancreatic deoxyribonuclease (DNase) 
which "nicks" or cuts one strand of the DNA. The DNA 
polymerase will then catalyse the addition of a 
nucleotide residue to the 3'-hydroxyl terminus of the nick 
(Fig. 5). At the same time the 5' to 3' exonucleasp 
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activity of this enzyme will eliminate the nucleotide unit 
from the 5' -phosphoryl terminus of the nick. The net 
result of the reaction will be the incorporation of a new 
nucleotide with a free 3' -OH group at the position where 
the original nucleotide was excised. The nick will, 
therefore have been shifted along by one nucleotide unit 
in a 3' direction. Continued 3' shift, or translation, of 
the nick will result in the sequential addition of new 
nucleotides to the DNA while pre-existing nucleotides will 
be removed. 
The DNA thus acts as both primer for the DNA polymerase, 
because of its free 3' -OH group, as well as template, 
because the opposite strand of the DNA duplex dictates 
what type of nucleotide is to be incorporated. If radio-
actively labelled deoxyribonucleoside triphosphates 
(dNTPs) are used as substrates, the original unlabelled 
nucleotides in the DNA will be replaced by labelled ones. 
By means of this "hot for cold SWOp" of nucleotides, about 




The nick translation reaction has to be carried out slowly 
and at fairly low temperatures eg incubation for 60 
minutes at 15°C. This requires caref ul monitoring because 
at higher temperatures 'snap back' DNA (Fig. 6) may be 
generated and thus affect the efficiency of labelling 
(Maniatis et al., 1982). 
--
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Fig. 5. . A schematic representation of the nick translation reaction. 
1 Intact double stranded DNA 
2 A nick produced by the enzyme DNase 1 
3 The first nucleotide has been replaced by a labelled 
nucleotide and it has been moved along in a 5' to 3' direction 
4 The nick has been translated two more positions along the DNA 
(Matthew, 1983) . 
.. , 
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Fig. 6 A. 
B. 
". 
.. ----- .. 
Nick translation reaction at optimal temperature 
Formation of "snapback" DNA at higher temperatures 
(Adapted from Maniatis et ~., 1982). 
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2.7 PROPERTIES OF LABELLED DNA 
... 
The most important property of the DNA probe is its -
specific activity. The higher the specific activity, the 
more sensitive and accurate the detection and 
quantification of specific sequences will be. In order to 
make a probe of high specific activity, sufficient 
labelled nucleotide must be added to the reaction mixture 
to replace all the corresponding nucleotides in the DNA. 
For instance, if 4000 picomoles (pmol) of DNA are to be 
labelled, then 1000 pmol of dCTP will be required to 
replace all the "cold" dCTP, whereas 100 pmol could 
replace only 10% of it. In practice, an incorporation of 
30-50% is usually obtained. The specific activity of the 
probe will obviously also depend on the specific activity 
of the nucleotide(s) used in the nick translation. 
Adequate detection of unique sequences by Southern 
blotting for example, requires a probe with an activity of 
approximately 108 cpm/ug. 
The amount of DNase added to the reaction is also an 
important parameter. If the DNase concentration is high 
many nicks will be generated and the DNA polymerase can 
begin translating at many sites. The reaction rate will 
therefore be high, and a probe of high specific activity 
will be generated in the standard incubation time, 
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although the single stranded length of the labelled probe, 
and hence its subsequent rate of hybridisation to 
complementary sequences, will be reduced at such high 
DNase concentrations. Thus, for most applications only 
sufficient DNase i s added to produce a probe with a 
Single stranded length of about 400 nucleotides. Another 
important requirement for a probe is that it should be 
labelled throughout at uniform specific activity. If, for 
example, a section of the probe is poorly labelled, a 
restriction fragment corresponding to that part of the 
probe might not be detected on a Southern blot. The 
stabi li ty of a nick translated probe on storage is 
dependent on the type of isotopic label used. A 32p 
labelled probe with a specific activity of 108 cpm/ug is 
stable for 7-8 days, after which its single stranded 
length declines rapidly. 32p labelled probes have a half 
life of 14 days, during which time the specific activity 
decreases accordingly. However, 3H probes may be stable 
for 6 to 9 months. Thus the amount of probe used in 
hybridisation (in ul) will depend upon its activity with 
respect to the half life of the isotope label. 
DNA can also be labelled in vivo. For example, labelled 
viral DNA can be extracted from virus-infected cells 
which have been grown in the presence of 32p. However, 
". 
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nick translation has several advantages in that labelled 
DNA can be produced in the absence of a tissue culture 
system, the DNA can be labelled to a much higher specific 
activity and DNA can be purified when convenient, stored 
and then labelled rapidly when required. 
2.8 HYBRIDISATION 
Considerable effort has been devoted by such workers as 
Meinkoth and Wahl (1985) to determine the parameters 
affecting hybridisation kinetics. Although much of this 
work was applied to the annealing of two complementary 
strands in solution, the general principles apply to mixed 
phase reactions, and to a large extent, to reactions 
involvjng self-complementary probes such as those 
generated by nick translation. 
Many of the factors which affect hybridsation rates also 
affect hybrid stability and can be expressed in these 
terms. The melting temperature (Tm) of a hybrid is 
affected by ionic strength, pH, probe length and base 
~composition of the probe as well as by the concentration 
of helix destabilizing agents such as formamide (Meinkoth 
and Wah 1, 1985). 
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For nick translated probes or single stranded probes 
longer than 100 nucleotides, melting temperature (Tm) 
decreases by 10C for every 1% of mis-matched base pairs 
(Boffey, 1983). This might suggest that filter 
hybridisation should be carried out under the most 
stringent conditions possible, that is, as close to the Tm 
of the expected hybrid as is compatible with hybrid 
stabiity and reasonable reaction rate. However, a common 
approach is to carry out hybridisation under conditions of 
relatively low stringency which allows a high rate of 
hybridisation and follows this with treatment to remove 
poorly matched probes. Most workers use temperatures of 
between 65 and 720C in the absence of formamide, or 37 to 
450C in the presence of 50% formamide, followed by a 
series of post hybridisation washes of increasing 
stringency, that is, at higher temperatures or, more 
commonly, lower ionic strengths. The use of SOS to assist 
in the removal of non-specifically bound probes is also 
commonplace. Using this approach, it is possible to 
detect related sequences and to gain some estimate of the 
extent of sequence relatedness (or degree of mis-matching) 
if filters are autographed following each wash (ARL, 
1985). 
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The above assumes first order kinetics for the 
hybridisation reaction, since the concentration of the 
probe should be in excess over that of the target 
sequences and the rate of hybridisation will then be 
proportional to probe concentration. However, in filter 
hybridisation, background problems dictate that relatively 
low concentrations of radioactively labelled probe be used 
in order to obtain high signal-to-noise ratios. The 
generally accepted view is that 10ng of probe/ml of 
hybridisation mi xture is opti mal when 10% dextran sulphate 
is present, with an increase to 50-100 ng/ml in the 
absence of dextran sulphate (ARL, 1985). These 
concentrations will usually be high enough to give first 
order kinet i cs for the reaction. The rate of hybridisation 
is increased by the ,use of de xtran sulphate or other 
polymers. This effect may be due to promotion of network 
formation by overlapping probe sequences. The increase in 
rate seen with dextran sulphate is more pronounced with 
increasing probe length and is not seen at all with 
oligonucleotide probes. It should however, be noted that 
the use of dextran polymers may also lead to increased 
backgrounds and it is important that hybridis~tion times 
should be optimised for signal-to-noise ratio (Meinkoth 
and Wahl, 1985) . 
... 
45 
CHAPTER 3 MATERIALS AND METHODS 
3.1 Specimen Collection and History 
3.1.1 Tissue specimens for dot blot hybridisation 
Autopsy blood specimens in addition to autopsy 
liver material were collected from patients who 
died of chronic hepatitis or HCC as well as from 
causes unrelated to liver diseases. The latter 
were used as controls. Autopsy material was 
collected 2-3 days following death of the patient. 
The liver specimens were stored at -70oC and the 
blood was analysed for HBV markers. 
Liver autopsy samples were collected as follows: nine 
samples from patients with chronic liver disease' 
(9/9 were HBsAg positive and 3/9 HBeAg positive), 
four samples from patients with cirrhosis (4/4 were 
HBsAg positive and 4/4 HBeAg negative), four samples 
from patients with HCC (4/4 were HBsAg positive and 
1/4 HBeAg positive) and ten samples from patients 
having died of unrelated causes. These ten patients 
had no HBV markers. 
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3.1.2 Tissue specimens for Southern blotting 
Tumour tissue specimens obtained as soon after death 
as possible from patients dying of HCC, or after 
resection of HCC, were collected by the Liver 
Research Unit, University of the Witwatersrand. 
Resected specimens were frozen in liquid nitrogen 
and stored at - 700 C. Of the 10 biopsy specimens 
collected: 9/10 were HBsAg positive, 4/9 being 
HBeAg negative and 5/9 HBeAg positive while 1/10 was 
negative for HBV markers. Liver as well as tumour 
tissue was collected from 2 patients who were both 
HBsAg positive and one of whom was HBeAg positive. 
3.2 EXTRACTION OF TOTAL CELLULAR DNA FROM LIVER or TUMOUR 
TISSUE 
Approximately 0.5g tissue was sliced on ice in a petri 
dish with a sterile scalpel blade. It was then homogenised 
under liquid nitrogen to a powder form and placed in a 
siliconised eppendorf tube containing 450ul of lysing 
solution (2% SOS, 0.05 M EOTA, 0.2 M NaCI, 0.1 M Tris-HCI, 
pH 8.2). To this mixture 5ul of proteinase K (10mg/ml in 
0.01 M Tris-HCI, pH 7.5) to a final concentration of 
100ug/ml was added and the tissue incubated overnight at 
370C. This was followed by phenol/chloroform extraction 
~and back extraction with 24:1 chloroform isoamyl 
alcohol. The aqueous phase was dialysed against a 1xTE 
47 
buffer overnight and treated with DNase free RNase. The 
phenol/back extraction was repeated and phenol was then 
removed by an ether extraction. DNA was concentrated and 
purified by passing it through an Elutip-d (Schleicher 
Schuell) column. The eluted DNA was ethanol precipitated 
using ammonium acetate at -70oe to yield highly purified 
DNA . 
3.2.1 Quantification of the extracted DNA 
The concentration of DNA in the sample was 
calculated following determina t ion of the optical 
density (OD) ratio at 260/280nm using an ultra 
violet U/V spectrophotometer, Beckman model 24. OD 
260/280 ratios of 1.6 or greater were acceptable. 
3.3 DOT BLOTTING 
Dot blotting was applied to autopsy material as described 
by Kafatos et ~., (1979), using Biorad dot blot 
. apparatus, and Hybond-N membranes. The apparatus was made 
up of a perspex platform, covered by a layer of thin 
rubber sheeting, over which a baselayer of Whatmann 3MM 
filter paper was placed followed by the Hybond-N 
membrane, both papers being moistened in a solution of 
ammonium acetate and sodium hydroxide (2 M NH~OAc, 0.04 M 
NaOH). Diluted DNA samples were loaded into the wells and 
• 
washed through with standard sodium citrate buffer (3 M 
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NaCI, 0.3 M NaCi). 
For dot blots, three liver samples were used from patients 
seropositive for both HBsAg and HBeAg, 14 from patients 
HBsAg positive but HBeAg negative, and two from patients 
seronegative for both markers (Table 2). Serum samples 
were also tested from one patient seropositive for both 
markers, and from nine HBsAg positive but HBeAg negative 
patients. HBsAg positive and negative control sera were 
also tested. 
A series of dilutions to 100pg DNA for each of the test 
samples and controls was tested. 
TABLE 2. 
























Autopsy test samples used for dot blot 
hybridisation 
HBV markers in blood Sample origin 
H8sAg HBeAg anti-e 1 i ver serum 
+ + + 
+ + + + 
+ + 
+ + + 
+ + + 
+ + + 
+ + 
+ + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + 
+ + + 
- - + 




3.4 RESTRICTION ENZYME DIGESTION OF EXTRACTED BIOPSY LIVER DNA 
Restriction enzyme digestion of extracted DNA was carried 
out prior to loading of samples onto the agarose gels. The 
enzymes used were Eco R1 and Hind 111 (Amersham). The 
amount of enzyme required to digest DNA depended upon the 
concentration of the enzyme in question. An example of a 
digest for a 20ul loading sample is given below. 
Example: 
If enzyme Eco R1 is supplied at 3000 units/500ul, then 1 
ul is equivalent to 6 units and 1 unit cuts 1 ug of DNA, 
thus 2 ul of enzyme is equivalent to 12 units which can be 
used to digest 12 ug or less DNA. 
In certain cases it was necessary to increase the amount 
of enzyme used to 5 units/ug of DNA to ensure complete 
digestion when incubated overnight. The completeness of 
digestion was monitored by adding 10ul aliquots of the 
digestion reaction mix to A DNA (2 ug of~ DNA). The 
digested DNA was electrophoresed together with a molecular 
weight marker 111 (Boehringer Mannheim). 
3.5 GEL ELECTROPHORESIS 
A perspex horizontal gel apparatus was used (Bethesda 
Research Laboratories). DNA was electrophoresed in 1% 
agarose in tris-borate running buffer (89 mM tris-borate, 
~ 
2.5 mM EDTA, pH 8.3 diluted 1:10 for use). The wells were 
loaded according to their size with a 1:6 dilution of 
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tracking dye (0.25 % bromophenol blue, 0.25 % xylene 
cyanol and 30 % glycerol in water). 
A Biorad powerpak (Type 500/200) was used to 
electrophorese the samples at a constant voltage of 30 V 
overnight. Ethidium bromide (10 mg/ml ) was used as a 
staining dye at a concentration of 0.1 ul/ml agarose. The 
electrophoresed gel was examined under UV light to 
visualise the DNA bands and excess gel was trimmed off. 
The gel was placed under a plastic cover at 40C until 
required for Southern blotting. 
3.6 SOUTHERN BLOTTING (Table 3) 
The electrophoresed gel was transferred to a container for 
sequential washings in: 0.25 M HCI (2x 20 min), distilled 
water (10 min), denaturing solution 0.5 M NaOH in 1 M NaCI 
(2x 20 min), distilled water (5 min) and finally 
neutralised in 0.5 M Tris in 3 M NaCI pH 7.4 (30 min). 
DNA was subsequently transferred to the Hybond-N nylon 
membrane by the technique of Southern (Fig. 7) and the 
filter baked in a vacuum oven at BOoC for 2 hr. 
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TABLE 3. Biopsy live r DNA used for Southern blot 
hybridisation 
Pt. HBV markers Sample OrIgIn 
HBsAg HBeAg Tumour Liver 
MJ + - + 
FM + + -PS + + -RM + + -RM + + -
Se - - + 
BN + + + 
MD + + + 
TV + + + 
JM + + + 
JM + + + 
MeD + + + 
gel 
20 x SSC solution 
.. 
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3 lb weight 
pap~r towels (tissues) 
~~~§~g1-- 2 chromatography pape fi lte rs 
~~~=/~7====7;d.l'----r--.. nit roc ell u 1 0 s e f i 1 er 
2 chromatography paper wicks 
Fig. "7. Illustration of Southern transfer. 
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3.7 PREPARATION AND EXTRACTION OF THE HBV DNA PROBE 
3.7.1 Preparation of the probe 
.. 
The entire 3.3Kb HBV genome, cloned into the 
plasmid pBR325 by Anne Moriaty of Georgetown 
University, Washington DC and grown in transformed 
E. coli HB101 was obtained. 
The HBV genome has been inserted into the 
chloramphenicol resistance site in pBR325. 
Tetracycline and ampicillin resistant colonies of E. 
coli HB101 containing the HBV DNA plasmid were 
replated twice onto nutrient agar plates in order 
to obtain pure colony growth. Either tetracycline, 
ampicillin or chloramphenicol was added to the warm 
nutrient agar before pouring of the plates. Singl~ 
colonies from the original "tetracycline growth 
colonylf plate, the original Ifampicillin growth 
colonylf plate and the original "chloramphenicol 
growth colonylf plate were used to inoculate plates 
containing these respective antibiotic containing 
media. The plates were then incubated at 370C 
overni ght. 
As expected, colonies were found only on the 
ampicillin and tetracycline containing plates. One 
colony from each plate was used to inoculate 10 ml 
.. 
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nutrient broth, which was then incubated overnight 
at 370 C with vigorous shaking. 
3.7.2 Maxiprep extraction of the probe 
The 10 ml overnight culture from above (3.7.1) was 
used to inoculate 1L of nutrient broth in a 2.5 L 
Erlenmeyer flask. This was then incubated with 
vigorous shaking at 370C for 3.5 hr until late log 
phase of growth was reached. Following this 
incubation, chloramphenicol was added at a 
concentration of 34 mg/ml (0.17g chloramphenicol 
was dissolved in 5 ml methanol) to inhibit 
chromosomal DNA synthesis. This culture mixture was 
further incubated at 370C for 21 hr with vigorous 
shaking. Each 1L volume was then decanted into 3 x 
500 ml bottles and spun at 7 000 rpm for 20 min at 
40 C in a 8eckman-J21 centrifuge using a JA-21 rotor. 
The pellets obtained were resuspended in 150 ml TE 
buffer and spun at 10 000 rpm for 20 min at 40 C. The 
pellet was resuspended in 20 ml of 25% sucrose in 
0.05 M Tris HCl, pH 8.0, ml lysozyme (stock 10 
mg/ml in 10 mM Tris-HCl, ph 7.5) was added and the 
bottle was left on ice for 30 min, 5 ml of Triton 
X-100 in Tris-HCl buffer (1 ml of Triton X-100 
10%, 12.5 ml 0.05 M EDTA pH 8.5, 5ml 1 M Tris-HCI 
pH 8.0, 81.5 ml sterile distilled water) was added 
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and incubated on ice for a further 10 min . After the 
addition of 0.85 ml of a solution of 10 mg/ml 
RNase, the mixture was spun at 20 000 rpm for 30 min 
at 4°C. The supernatant was poured into clean 
polyallomer tubes , 0.95 g/ml cesium chloride (CsCl) 
was added and the contents of the tube mi xed well. 
Ethidium bromide was added to a final concentration 
of 1 mg/ml and the mixture spun at 45 000 rpm for 36 
hr at 4°C in a Beckman L8-55 ultracentrifuge using a 
50Ti rotor. The lower band of plasmid DNA visualised 
by UV light was sucked off into a sterile tube using 
a sterile 2 ml syringe with an 18g needle. Ethidium 
bromide was extracted from the DNA solution with 
equal volumes of isoamyl alcohol. This aqueous phase 
was measured into a sterile tube and 2 volumes of 
sterile distilled water (in order to dilute the 
CsCl), plus 2 volumes of ethanol were added and the 
contents of the tube mi xed well. The tubes were 
covered with parafilm and left at -20°C overnight. 
The precipitated DNA was pelleted at 3 000 rpm for 
15 min at 4°C. The pellet was washed with 70% 
ethanol in TE buffer and re-spun at 3 000 rpm for 25 
min at 4°C. The final pellet was resuspended in TE 
buffer. The DNA concentration was calculated and the 
sample stored at -20°C. Purified HBV DNA was 
obtained by Eco R1 digestion, agarose 
electrophoresis and gel extraction. 
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3.B RADIOISOTOPE LABELLING OF THE PROBE BY NICK TRANSLATION 
Purified HBV DNA was nick translated with 32 P dCTP to a 
specific activity of 1 x10B. The DNA sample to be labelled 
was dissolved either in distilled water or in TE buffer to 
a final concentration of 200 ug/ml, to dilute impurities 
which might interfere in the labelling reaction. 
Appropriate volumes of DNA solution, nucleotide/buffer 
solution, radioactively labelled 32 P dCTP, water and 
enzyme solution were added sequentially to a 1.5 ml 
microfuge tube which was placed in an ice bath. The tube 
was capped and the contents mixed gently. This tube was 
then placed in a constant temperature bath carefully 
o 
controlled at 15C, to avoid the generation of "snap back" 
DNA which may be formed by DNA polymerase copying the 
newly synthesised strand at higher temperatures (Fig. 6). 
The progress of the reaction was monitored to determine 
the exact reaction time giving the highest specific 
activity. To monitor counts as well as to measure the 
percentage incorporation of the label, 2 ul of the 
reaction mix was added to 100 ul of carrier DNA (stock 
solution of 50 ug/ml). Of this, 10 ul was spotted onto a 
GF/C filter paper for total counts. To the remaining 90 ul 
~ reaction mix, 2-4 ml of 10% cold TCA was added, the tube 
placed inan ice bath for 10 min and the precipitated DNA 
collected by vacuum filtration on a GF/C filter disc. The 
58 
filters were counted for 1 min using the 3H channel of 
the Beckman LS-250 scintillation counter without 
scintillation fluid. 
% incorporation = ppt counts x 100 
total counts x 9 
The labelled probe was passed through a column of Sephadex 
G 50 in order to separate labelled from unlabelled 
nucleotides. 
Pure vector pBR325 was also labelled and used as a 
negative control to probe the dot blots. 
3.9 HYBRIDISATION OF PROBE TO SOUTHERN AND DOT BLOTS 
A modification of Maniatis's hybridisation method was 
applied to dot blot hybridisation of autopsy liver DNA. 
The Southern blots of biopsy liver DNA (Table 3) were 
hybridised as follows: 
The blot was labelled, wet in 2 x SSC and placed in a 
plastic bag. To the 5 ml prehybridisation solution 10 
ml ' 1 M Hepes pH 7.0, 20 ml 100 x Denhardts, 0.2 ml 
poly A {10 mg/ml, 30 ml 20 x SSC, 2 x stock diluted 1:1 
with deionised formamide), 5 m·I of deionised formamide 
and 100 ul of herring sperm DNA (5 mg/mI) was added. This 
Qremix was prewarmed to 42 0C and added to the blot which 
was prehybridised for 6 hr at 420C. The final 
hybridisation solution was prepared by adding 2.5 ml of 
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the prehybridisation solution (to which 20 g of dextran 
sulphate in 30 ml of water was ·added), to 2.5 ml of 
deionised formamide and 100 ul of herring sperm DNA. The 
premix was removed and the warmed hybridisation mix with 
the denatured label led probe was added to the blot which 
was allowed to hybridise for 24 hr at 420 C. The filters 
were removed, rinsed twice in 2 x SSC for two periods of 
30 min each. Prewarmed 0.1 x SSC, 0.1% SOS was then added 
and the filters were shaken at 550C for two periods of 30 
min each. The blots were finally rinsed in cold 0.1 x SSC, 
0.1% SOS for two periods of 30 min each. The blots were 
then taped onto a filter paper, the position of the gel 
slots marked with labelled "blue ink", the blots sealed 




CHAPTER 4 RESULTS 
HBV DNA has been strongly implicated as having a causal role in 
HCC, the presence of HBV DNA in cirrhosis being reported for 
the first time by Koshy et ~., in 1981. It is therefore to be 
expected that valuable information regarding the pathogenesis 
of acute and chronic liver disease following HBV infection 
could be obtained from studies on the state of HBV DNA in the 
infected liver cells. 
4.1 DOT BLOT HYBRIDISATION 
... 
Of the 17 HBsAg positive autopsy patients, 13 (76%) showed 
the presence of HBV DNA in the liver (6/9 with chronic 
liver disease, 4/4 with cirrhosis, and 3/4 with HCC). 
Visual examination of the dot blots indicates that 
patients positive for both HBsAg and HBeAg show the 
strongest hybridisation signals (Figs. 8 and 9). Thus one 
could surmise that there is a greater concentration of HBV 
DNA in the liver of these patients. It is therefore 
possible that, for these patients, the positive 
hybridisation on the dot blots was due to replicative HBV 
or episomal HBV, suggesting a high infectivity and active 
liver disease. 
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All but one of the remaining ten HBV DNA hybridisation 
positive patients have HBsAg values one degree of 
magnitude greater than the values seen in the HBsAg 
positive patients fo r whom no HBV DNA integration could be 
detected (Table 4). 
The RIA values effectively divide the patients into three 
main categories. The first contains patients with 
extremely high values for HBsAg who were additionally 
HBeAg posi t ive and who were all strongly positive for HBV 
DNA hybridisation; the second category includes HBeAg 
negative patients with a lower level of HBsAg positivity 
but also positive for HBV DNA hybridisation; the third 
category consists of patients negative for both HBsAg and 
HBeAg and with no evidence of HBV DNA association. In this 
study there therefore appears to be an inverse 
relationship between HBsAg status and the presence of HBV 
DNA in the liver as determined by dot blot hybridisation 
with the labelled probe. 
All of the contro l patients with normal livers were 
negative for HBsAg, HBeAg and HBcAb. They could thus be 
assumed to have had no exposure to HBV. For most of these 
patients dot blot hybridisation was negative even when a 
12 ug DNA sample was used. However some reactivity, which 
was attributed to non-specific binding of the probe, was 
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observed in one case (Fig. 9), and all positive results 
were therefore taken from the second row where 1 ug DNA 
samples were loaded. 
As it had been found necessary to use entire pBR325 HBV 
DNA as the probe in these experiments a further control 
consisting of 32p pBR325 was introduced (Maniatis et ~. , 
1982; Steyn, 1986). However, attempts to hybridise the 
labelled plasmid to samples of DNA showing positive 
hybridisation with 32p pBR325 HBV DNA were unsuccessful and 
it was therefore concluded that HBV specific hybridisation 
had been obtained when using the entire 32p pBR325 HBV 
DNA probe. 
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TABLE 4. HBsAg and HBeAg status related to the detection of 
HBV DNA in autopsy liver on dot blot hybridisation 
with the labelled probe 
Pt No. RIA values HBV DNA 
--- sAg eAg hyDrTdisation 
2 11300 3000 + 
3 11186 3689 + 
6 10067 3988 + 
15 9758 4312 + 
1 8613 - + 
5 7435 - + 
10 7428 - + 
12 7400 - + 
9 7326 - + 
11 7100 - + 
13 6549 - + 
17 6416 - + 
14 452 - + 
4 399 - -
7 307 - -
16 286 - -
8 203 - -
.. 
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Pt No. 2 10 12 21 1 16 15 14 
12"9 
100 n9 
Fig. 8. Dot blot hybridisation of autopsy liver DNA. 
HBsAg positive: 
Pts 1,2 hepatitis liver DNA 
Pts 10,12 : cirrhotic DNA 
Pts 14,15,16: HCC DNA 
HbsAg negative: 
Pt 21 : normal liver DNA. 
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normal liver DNA. 
Patient 15 was additionally HBeAg positive. Patient 26 
• 
shows non-specific binding at 12 ug DNA but is negative 
for hybridisation at 1 ug DNA. 
66 
4.2 GEL ELECTROPHORESIS 
Gel electrophoresis of autopsy liver DNA produced 
inconsistant bandi ng patterns and was thus unsuccessful. 
According to Dr. J. Dusheiko (pers comm) , this was due to 
the long time interval between death and post mortem 
examination. This time interval should be as minimal as 
possible (1/2 to 1 hr) to avoid loss of DNA as well as 
degradation. 
Completeness of digestion of cellular DNA by the enzymes 
Eco R1 and Hind 111 was monitored by the addition of~ DNA 
to the samples. Electrophoresed gels of digested DNA were 
examined for the different banding patterns produced 
with the restriction enzymes (Fig. 10). 
Gel electrophoresis of undigested and digested biopsy 
liver DNA produced smears extending from approximately 
21 Kbp to below 0.125 Kbp (Fig. 11), which is apparently 
typical of liver DNA (Dr. J. Dusheiko pers. comm.). 
Molecular weight marker 111 (Boehringer Mannheim) was 
electrophoresed together with the liver DNA so as to 
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Eco R1 digested biopsy liverDNA '+>-DNA 
Hind 111 digested biopsy liver DNA+ ~DNA 
molecular weight marker 111 
und i gested A. DNA 
Eco Rl digested A DNA 
Hind 111 digested A DNA. 
The patterns obtained with the Eco R1 and Hind 111 
digested A DNA indicates that complete digestion has 
taken place. Thus the conditions used for enzyme digestion 


















Gel electrophoresis of biopsy liver DNA. 
molecular weight marker 111 
Lanes 2,3,4 
Lanes 6,7,8 
Pt BN Eco R1, Hind 111 and undigested DNA 
Pt TV Eco R1, Hind 111 and undigested DNA 
In the above example the smears are indicative of total 
cellular DNA. Bands are visible in the region of 21 Kbp, 
which continue as smears down the respective lanes to 
below , 0.564 Kbp. The conditions for digestion were as for 
the samples in Fig. 10 . 
• 
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4.3 HBV DNA Integration (Southern blotting) 
There appears to be no simple correlation between HBV 
markers in the serum and HBV DNA in the tumour. HBV DNA 
integration into tumour tissue was originally observed 
only in patients who were HBsAg positive (Shafritz and 
Kew, 1981). However, Lugassy et ~., (1987), have reported 
the presence of HBV DNA sequences in liver samples of 
patients who were HBsAg negative and also in patients who 
had no HBV markers at all. The HBV DNA sequences included 
free monomeric and integrated forms similar to the 
restriction ,patterns seen in HBsAg positive patients. 
The various forms of HBV DNA in liver biopsies were 
examined using the enzymes Hind 111 and Eco R1, which 
cleave HBV DNA at zero and one site respectively. The 
restriction patterns obtained suggest the presence of 
replicative HBV DNA intermediates with the presence of 
single stranded HBV DNA and thus ongoing HBV replication. 
If HBV DNA is integrated into cellular DNA, both 
undigested and Hind 111 digested material will produce a 
diffuse hybridisation smear in the high molecular weight 
region, as Hind 111 digestion will produce bands greater .. 
than HBV genome size (>3.3 Kb). However, if HBV DNA is 
not integrated, undigested and digested total cellular 
DNA will have the same banding pattern and hybridisation 
will occur in the low molecular weight region of the gel 
.. 
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at or below the position of 3.3 Kbp. Following Eco R1 
digestion, sequences greater than genome size ( > 3.3Kb) 
showing a hybridisation signal, must have been derived 
from integrated HBV DNA (Shafritz et ~., 1981) 
Hybridisation signals at the 3.2Kb position are indicative 
of cloned monomeric HBV DNA. Smears of DNA located in the 
low molecular weight region reflect the presence of 
single-stranded (0.5 - 1.5 Kb) and partially double 
stranded replicative intermediates (2 - 2.8 Kb) (Lugassy 
et a I ., 1987) . 
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RC-




-- 2 Kb 
-- t5kb 
Fig. 12. The various forms of HBV DNA (and their 
respective sizes) which can be present in the liver 
following HBV infection: RC - relaxed circular form, L-
linear, PDS - partially double stranded, SC - super-coiled 
and SS - single- stranded HBV DNA. Below 3.2 Kb and above 2 
Kb the linear and partially double stranded forms of the 
virus are present (Lugassy et~., 1987) . 
... 
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Failure to detect HBV DNA integration by Southern blot 
hybridisation does not necessarily indicate that no 
integration has occurred. Boender et al., (1985), have 
suggested that failure to detect specific integration on 
Southern blots could be due to the presence of insertions 
or deletions occurring during or after the integration 
into the host cell genome. Also Bowyer et ~., (1987) 
have shown that the HBV DNA copy number is crucial in 
Southern blot analysis. They found that samples with a low 
HBV DNA copy number failed to show HBV DNA hybridisation 
on blots . 
... 
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4.3.1 HBV DNA status in patients who were HBsAg and HBeAg 
positive. 
<t. 
The results of the Southern blots indicated the 
presence of HBV DNA in the liver of 5/5 (100%) HCC 
patients with this marker profile. Two HCC patients 
(BN and MD) showed integrated as · well as free 
repiicative fo rms of HBV DNA in the tumur tissue (eg 
Pt MD, Fig. 13). This could be due to some cells 
having integrated the HBV DNA whereas others still 
have the replicative forms present. Another 
possibility is that there is a transition from HBeAg 
positivity to the anti-HBe status which could mean 
that the patient is no more infectious and is moving 
towards a chronic carrier state with a percentage of 
HBV DNA being integrated into the cellular DNA. 
A further two patients (McD, Fig. 14 and TV, Fig. 
15) showed only replicative intermediates in tumour 
tissue. These replicative intermediates appear to 
include relaxed circular, partially double stranded, 
supe~coiled and single stranded forms of the virus 
ie freely replicating episomal HBV DNA. 
The last patient (JM) showed extrachromosomal HBV 
DNA in the liver (Fig. 16), however, for the same 
patient there was no detectable HBV DNA in the 
tumour. 
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Two of the patients with integrated HBV DNA (eg Pt 
MD Fig. 13), showed a specific banding pattern on 
Hind 111 digestion suggesting HBV DNA integration 
into specific sites on the cellular genome, and 
supporting the results of Shafritz et ~., 1981). 
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Fig. 13. 
A comparison of the enzyme digests with the undigested 
material indicates integration of HBV DNA as 
hybridisation signals continue to appear in the high 
molecular weight region (21 Kbp). An examination of the 
Hind 111 lane shows at least two hybridisation bands 
greater than HBV genome size, suggesting integration into 
specific sites on the host cell genome. 
There is also a diffuse hybridisation smear down the 
lane, indicating a range of forms of HBV DNA, with a 
strong band of supercoiled DNA at the 2 Kbp position. 
Thus the tumour cells of this patient contain both 
integrated and/or free HBV DNA. 










Patient MO - Southern blot analysis of HBV DNA in 
tumour tissue. 
lane 1 ~co R1 digest 
lane 2 .' Hind 111 digest 
'Lane 3 undIgested tumour DNA 
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Fig. 14. 
There appears to be no integration of HBV DNA into host cell 
chromosomal DNA as seen by the absence of a hybridisation 
signal in the high molecular weight region of the blot. 
However, free replicative intermediates of HBV DNA are clearly 
present in the region of 3.2 Kbp to below 1.5 Kbp. These 
intermediates include relaxed circular, partially double · 
stranded, supercoiled and single stranded forms. In addition a 
strong band is seen at the 5.1 Kbp position. However, as this 
band occurs in all three lanes it is not considered equivalent 
to the 5.1 Kbp band in the Hind 111 lane of Fig. 13. Rather it 
might reflect the presence of HBV DNA covalently linked to 
cellular DNA, or may be due to multimeric or free dimeric HBV 
DNA. According to Lugassy et ~., (1987), these viral forms are 

















Eeo R1 digested tumour DNA 
Hind 111 digest 
uQdigested tumour DNA 
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Fig. 15 
There is no high molecular weight hYQridisation signal in 
any lane, indicating an absence of HBV DNA integration. 
In each of the lanes a diffuse hybridisation pattern 
appears as a smear extending from 3.5 Kbp to below 0.983 
Kbp. However, HBV DNA sequences are present at the same 
position as double stranded full length HBV DNA (3.2 Kbp) 
and it is possible that single stranded (1.5 Kbp) and 
partially double stranded sequences are present in the 
lower base pair region. 
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JM (L) 







Patient JM(L) - Southern blot analysis of HBV DNA in 
liver tissue. 
Lane 1 Eco R1 digest .. 
Lane 2 Hind 111 digest 
Lane 3 undigested liver DNA 
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Fig. 16. 
There is no hybridisation in the high molecular 
weight region indicating the absence of HBV DNA 
integration. In each lane a diffuse hybridisation 
pattern is seen as a smear extending from 3.5 Kbp to 
below 0.983 Kbp, indicating free extrachromosomal 
HBV DNA in the form of relaxed circular HBV DNA at 
the 3.2 Kbp position and linear forms of the virus 
below this position followed by the partially double 
stranded forms. There is also evidence of 
supercoiled forms at 2 Kbp and single stranded HBV 
-DNA at 1.5 Kbp positions. 
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TV 





Patient TV - Southern blot analysis of HBV DNA in 
tumour tissue. 
Lane Eco R1 digest 
Lane 2 Hind 111 digest 
Lane 3': undigested tumour DNA 
... 
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4.3.2 HBV DNA status in HBsAg positive, HBeAg negative 
patients 
3/4 (75%) tumour patients who were HBsAg positive 
and HBeAg negative showed hybridisation signals on 
the Southern blots which indicated integrated HBV 
DNA sequences (Pts. FM, MJ and PS, Figs. 17 and 18). 
All of these patients appeared also to have 
replicative intermediates (eg Pt FM Fig. 18). This 
is in contrast to the results of Lugassy et al., 
(1987), who did not find any patients who had both 
integrated as well as free viral DNA. This pattern 
apparently reflects low viral replication. A 
specific band greater than HBV genome size was again 
present for the Hind 111 digested material, 
suggesting specific site integration of HBV DNA into 
the human genome. 
The finding of HBV DNA integration in these patients 
who were HBsAg positive and HBeAg negative could 
carry the following implications: 
(a) le l Ag is totally absent and only s genes are 
~ expressed either with the entire HBV genome being 
integrated or with only s genes integrated 
(b) It is possible that 'e'Ag is actually present 
but in small amounts undetectable by the 
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conventional radioimmunoassay. 
This may be due to integration of the entire HBV 
genome with both s gene and minimal e gene 
expression, or to integrated s gene expression 




Diffuse hybridisation with high molecular weight material 
greater than HBV genome size (4.21 - 21 Kbp) is seen in 
the Eco R1 digest, with more distinct regions of high 
molecular weight hybridisation appearing in the Hind 111 
digest and the undigested DNA, indicating the presence of 
integrated HBV DNA. A diffuse hybridisation smear of 












Patient PS - Southern blot analysis of HBV DNA in tumour 
tissue. 
Lane 1 Eco R1 digest 
Lane 2 Hind 111 digest 




The presence of high molecular weight hybridisation 
signals in all three lanes indicates that integrated HBV 
DNA was present in the tumour. The Hind 111 digest is 
similar to that seen in Fig. 17. The Eco R1 digest suggests 
the presence of concatomers or oligomers of HBV DNA as 












Patient FM - Southern blot analysis of HBV DNA in tumour 
tissue. 
Lane 1 Eeo R1 digest 
• 
Lane 2 Hind 111 digest 
Lane 3 undigested tumour DNA 
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TABLE 5. Summary of HBV DNA status in biopsy liver/tumour 
specimens 
HBV marker HBV DNA status in liver 
Pt sAg/eAg Integrated / extrachromosomal 
BN + + + + 
TV + + - + 
MD + + + + 
MeD + + - + 
JM(L) + + - + 
JM(T) + + - -
Se - - - -
PS + - + + 
MJ + - + + 
FM + - + + 
RM(L) + - - -
RM(T) + - - -
... 
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CHAPTER 5 DISCUSSION 
Viral infectivity during the acute and chronic phases of HBV 
infection is estimated by the detection of HBV markers. 
However, these provide an indirect estimation ~f active viral 
replication. The determination of HBV DNA in the serum of 
infective carriers is a more direct and quantitative analysis 
of the presence of Dane particles. In a study by Brechot et 
al., (1981), HBV DNA was found in 70 - 95% of HBeAg positive 
sera from HBsAg chronic carriers. Positive HBV DNA in the 
serum corrrelates closely with replicative HBV infection, and 
also correlates with the presence of replicative intermediates 
in liver tissue and thus with active liver disease (Matsuyama 
et ~., 1985). 
In the course of this study molecular biology techniques and 
methods which could be used in the routine determination of 
the association of HBV with hepatitis, cirrhosis and HCC were 
utilised. Dot blot and Southern blot methods of hybri~isation 
proved useful in detecting HBV DNA sequences in the diseased 
liver of patients seropos itive for HBsAg, thus supporting an 
aetiological role for HBV . 
... 
HBV DNA in the liver was detectable by dot blot hybridisation 
in (13/17) 76% of the autopsy patients who were HBsAg 
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positive. Even although dot blot hybridisation does not 
distinguish integrated from non-integrated forms of HBV DNA, it 
is a relatively quick and easy method involving the direct use 
of the extracted DNA from the tissue, and would thus be readily 
applicable in the routine diagnostic laboratory. 
HBV DNA hybridisation was not detected by Southern blot 
analysis of autopsy liver material. The same problem was 
reported by Shafritz et~., (1981), who found that extensive 
liver fibrosis, ~s well as DNA degradation due to the long time 
interval between death and post mortem examination may have 
led to dilution of HBV sequences and thus negative results on 
their blots. 
However, Southern blot hybridisation proved useful for the 
analysis of liver biopsy material, distinguishing integrated 
from non-integrated HBV DNA sequences with the use of the 
enzymes Eco R1 and Hind 111. Hind 111 digestion has shown that 
of the tumour biopsy patients 5/9 (56%) had integrated HBV DNA 
sequences. These results tend to confirm those of Bonino et 
al., (1981), that HBV DNA in the liver is predominantly 
integrated in patients with HBV - related hepatocellular 
carcinoma. However, in this study low molecular weight 
sequences of HBV DNA (replicative intermediates) ' were also 
detected in all 5 tumour patients with integrated sequences. 
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Bowyer et~., (1987) detected episomal but not integrated HBV 
DNA in HBeAg positive carriers of HBsAg. In contrast, the 
results of this study showed that while all five patients with 
this marker pattern had episomal ~BV DNA in the liver or tumour 
tissue, the hybridisation patterns for two of these patients 
indicated that integration of HBV DNA had also taken place. 
Conversely the three HBsAg - positive HBeAg - positive patients 
with integrated HBV DNA were simultaneously carrying episomal 
DNA in the tumour tissue, although it might be expected that 
viral replication would have ceased in these patients (Bowyer 
et al., 1987). --
Nevertheless, regardless of inferences which might be drawn 
from the presence of episomal HBV DNA, the detection of 
integrated HBV DNA in cellular DNA of tumour tissue supports 
the hypothesis. that HBV is a factOr in human hepatocellular 
carcinoma. 
With chronic alcohol abuse or cirrhosis the sensitivity of the 
liver to exposure to agents with oncogenic potential is 
incr~ased (Beasley and Hwang, 1984), and this could explain 
possible progression to HeC. The association of HBV with HCC 
has best been investigated by epidemiologic studies, since 
studies of HBV gene expression have not revealed the presence 
93 
of a transforming gene or an associated oncogene (Murray et 
al., 1981). In order to prove that integrated HBV DNA may have 
a causal role in the deve lopment of neoplasia, it will first be 
necessary to demonstrate in tissue culture the expression of 
integrated HBV , genes following HBV infection (Wen et al., - -
1983), since it is possible that integration of the HBV DNA 
sequence results in the alteration of adjacent cellular gene 
expression. However, the majority of experiments relating to 
HBV DNA integration have used human fibroblast or monkey kidney 
cells as the recipient cell whereas the most appropriate cells 
to use would be cultured human hepatocytes (Sherman and 
Shafritz, 1984). 
By the recombinant DNA techniques used in this study one could 
routinely detect integration of HBV DNA into the human genome. 
It is possible , that detection of integrated HBV, DNA could 
result in treatment leading to the subsequent decrease of HBV 
DNA copy number and thus result in a probable decrease in 
percentage integration (Boender et ~., 1985). Thus since 
integrated HBV DNA has been implicated as a cofactor in HCC, a 
decrease in this integration could probably result in decreased 
progression to HCC and a longer lifespan for the affected 
.. 
individual. 
However, if HBV DNA integration is in some way responsible for 
the high levels of morbidity and mortality aSSociated with 
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chronic acute hepatitis, cirrhosis and HCC in many parts of the 
world the best approach to reduction of such morbidity and 
mortality would be the prevention of HBV infection in the first 
place. 
Definitive control of HBV infection would require an extensive 
world-wide programme of vccination. Unfortunately, the 
currently available hepatitis B vaccine which is , produced from 
human plasma containing HBsAg does not provide the appropriate 
means as the costs involved in the production of the vaccine 
are prohibitive for its use in developing countries which have 
most need for it. However, recombinant DNA technology enables 
the synthesis of HBsAg by the cultivation of microorganisms and 
thus could guarantee a continued inexpensive supply of uniform 
antigens for vaccine use. 
The process bf gene cloning in genetic research has sparked a 
new revolution in modern biology, involving the use of living 
organisms or subcellular components derived from living 
organisms. Gene cloning has the capacity to make direct 
alterations to the characteristics of a living organism and 
also to study these alterations at molecular level. Thus these 
techniques applied to the study of HBV infection could provide 
possible answers as to the mechanisms and effects of HBV DNA 
integration into the human genome, and thereby lead to a better 
understanding of the pathogenesis and development of HCC, as 
well as sugg~sting possible lines of approach for therapeutic 
intervention at the cellular level or for control of initial 
HBV infection. 
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